Analyzer | Biosafety Clearing-House

Article 2 – General provisions

(Questions 7 - 13

Question 7

Has your country introduced the necessary national measures for the implementation of the Protocol?

	Total	%	AFR	Asia	CEE	GRULAC	WEOG
National measures are fully in place	64	44	10	9	10	2	14
National measures are partially in place	66	45	17	11	5	12	1
Only temporary measures have been introduced	6	4	1	3	0	0	0
Only draft measures exist	9	6	1	1	0	3	0
No measures have yet been taken	1	1	0	1	0	0	0

Question 8

Which specific instruments are in place for the implementation of national biosafety measures? (select all that apply)

	Total	%	AFR	Asia	CEE	GRULAC	WEOG
One or more national biosafety laws	95	26	7	5	5	3	6
One or more national biosafety regulations	93	26	7	6	4	4	5
One or more sets of biosafety guidelines	73	20	6	5	3	2	3
Other laws, regulations or guidelines that indirectly apply to biosafety	100	27	10	7	4	4	4
No instruments are in place	3	1	1	0	0	0	0

Question

Please provide further information on the instruments in place:

		Total	%		AFR		Asia		CEE		GRULAC		WEOG
	Free text	100			34		22		12		18		14

Question 9

Has your country integrated biosafety in national sectoral and cross-sectoral strategies, action plans, programmes, policies or legislation?

	Total	%	AFR	Asia	CEE	GRULAC	WEOG
Yes	79	54	14	11	12	6	11
Yes, to some extent:	60	41	14	13	3	9	2
No	7	5	1	1	0	2	1

Question 10

Does your country have resources for biosafety from national budgets?

		Total	%		AFR		Asia		CEE		GRULAC		WEOG
	Yes	102	70		18		17		12		10		12
	No	44	30		12		8		2		7		2

Question

Are these resources adequate:

		Total	%		AFR		Asia		CEE		GRULAC		WEOG
	Yes	38	39		0		8		12		1		17
	No	60	61		26		17		5		12		1

Question 11

Does your country have qualified staff to administer functions directly related to biosafety?

		Total	%		AFR		Asia		CEE		GRULAC		WEOG
	Yes	133	91		27		21		14		15		14
	No	13	9		3		3		1		2		0

Question 12

If you answered Yes to question 11, how many qualified staff members are in place whose functions are directly related to biosafety?

	Total	%	AFR	Asia	CEE	GRULAC	WEOG
1 to 4	48	36	12	9	7	7	2
5 to 9	19	14	5	2	2	3	3
10 or more	66	50	13	13	6	7	11

Question

Is this number adequate:

		Total	%		AFR		Asia		CEE		GRULAC		WEOG
	Yes	52	39		3		8		11		3		15
	No	81	61		26		16		5		14		1

Question 13

Please use the space below to provide further details on the implementation of Article 2 in your country:

		Total	%		AFR		Asia		CEE		GRULAC		WEOG
	Free text	123			39		30		18		17		19

Article 5 – Pharmaceuticals

(Questions 14 - 15

Article 6 – Transit and contained use

(Questions 16 - 19

Articles 7 to 10: Advance informed agreement (AIA) and intentional introduction of LMOs into the environment

(Questions 20 - 30

Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)

(Questions 31 - 36

Article 12 – Review of decisions

(Questions 37 - 44

Article 13 – Simplified procedure

(Questions 45 - 49

Article 14 – Bilateral, regional and multilateral agreements and arrangements

(Questions 50 - 52

Articles 15 & 16 – Risk assessment and risk management

(Questions 53 - 72

Article 17 – Unintentional transboundary movements⁵ and emergency measures

(Questions 73 - 78

Article 18 – Handling, transport, packaging and identification

(Questions 79 - 97

Article 19 – Competent national authorities and national focal points

(Questions 98 - 101

Article 20 – Information-sharing and the Biosafety Clearing-House (BCH):

(Questions Q102_a - 108

Article 21 – Confidential information

(Questions 109 - 111

Article 22 – Capacity-building

(Questions 112 - 126

Article 23 – Public awareness and participation

(Questions 127 - 139

Article 24 – Non-Parties

(Questions 140 - 144

Article 25 – Illegal transboundary movements ⁷

(Questions 145 - 148

Article 26 – Socio-economic considerations

(Questions 149 - 152

Article 28 – Financial mechanism and resources

(Question 153)

Article 33 – Monitoring and reporting

(Question 154)

Cooperation

(Questions Q155_a - 158

Nagoya – Kuala Lumpur Supplementary Protocol on Liability and Redress

(Questions 159 - 174

Other information

(Question 175)

Comments on reporting format

(Question 176)

CPB - Fifth National Report

Report: CPB - Fifth National Report

Analysis: Breakdown by CBD regions

The current analysis is filtered to show only reports where

Article 2 – General provisions

Article 5 – Pharmaceuticals

Article 6 – Transit and contained use

Articles 7 to 10: Advance informed agreement (AIA) and intentional introduction of LMOs into the environment

Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)

Article 12 – Review of decisions

Article 13 – Simplified procedure

Article 14 – Bilateral, regional and multilateral agreements and arrangements

Articles 15 & 16 – Risk assessment and risk management

Article 17 – Unintentional transboundary movements⁵ and emergency measures

Article 18 – Handling, transport, packaging and identification

Article 19 – Competent national authorities and national focal points

Article 20 – Information-sharing and the Biosafety Clearing-House (BCH):

Article 21 – Confidential information

Article 22 – Capacity-building

Article 23 – Public awareness and participation

Article 24 – Non-Parties

Article 25 – Illegal transboundary movements ⁷

Article 26 – Socio-economic considerations

Article 28 – Financial mechanism and resources

Article 33 – Monitoring and reporting

Cooperation

Nagoya – Kuala Lumpur Supplementary Protocol on Liability and Redress

Other information

Comments on reporting format

Quick links

Need help?

THE CONVENTION ON BIOLOGICAL DIVERSITY

Quick Links

Topics

Information

A part of

CPB - Fifth National Report

Report: CPB - Fifth National Report

Analysis: Breakdown by CBD regions

The current analysis is filtered to show only reports where

Article 2 – General provisions

Article 5 – Pharmaceuticals

Article 6 – Transit and contained use

Articles 7 to 10: Advance informed agreement (AIA) and intentional introduction of LMOs into the environment

Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)

Article 12 – Review of decisions

Article 13 – Simplified procedure

Article 14 – Bilateral, regional and multilateral agreements and arrangements

Articles 15 & 16 – Risk assessment and risk management

Article 17 – Unintentional transboundary movements5 and emergency measures

Article 18 – Handling, transport, packaging and identification

Article 19 – Competent national authorities and national focal points

Article 20 – Information-sharing and the Biosafety Clearing-House (BCH):

Article 21 – Confidential information

Article 22 – Capacity-building

Article 23 – Public awareness and participation

Article 24 – Non-Parties

Article 25 – Illegal transboundary movements 7

Article 26 – Socio-economic considerations

Article 28 – Financial mechanism and resources

Article 33 – Monitoring and reporting

Cooperation

Nagoya – Kuala Lumpur Supplementary Protocol on Liability and Redress

Other information

Comments on reporting format

Change how numbers are calculated

Percentage overall

Percentage by column

Percentage by row

Count of responses

Question .

Quick links

Need help?

THE CONVENTION ON BIOLOGICAL DIVERSITY

Quick Links

Topics

Information

A part of

Article 17 – Unintentional transboundary movements⁵ and emergency measures

Article 25 – Illegal transboundary movements ⁷